Drug intelligence / Profile preview

Vivinox

Development stage
Unknown
Lead developer
Bausch + Lomb
Modality
Small Molecules
01

Overview

Vivinox is a brand of over-the-counter (OTC) pharmaceutical products developed by Dr. Gerhard Mann (a subsidiary of Bausch + Lomb) primarily indicated for the short-term treatment of sleep disorders and nervous restlessness. The product line includes **Vivinox Sleep**, which utilizes **diphenhydramine hydrochloride**, a first-generation antihistamine that acts as an antagonist at the histamine H1 receptor to induce sedation. The brand also encompasses herbal formulations, such as **Vivinox Nervenruhe**, which contain extracts of **valerian root**, **lemon balm**, and **passionflower**. These herbal components are traditionally used to alleviate restlessness and facilitate sleep, likely through the modulation of GABAergic signaling in the central nervous system. These products are marketed in Germany as pharmacy-only medications for symptomatic relief.

Brand names
VivinoxVivinox SleepVivinox NervenruheVivinox Day
Other names
Vivinox-Dr. Gerhard Mann
02

Targets

HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on Vivinox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivinox.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call